Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Alvotech Gets A Fresh Date For Adalimumab In US
Expects FDA Reinspection Ahead Of 24 February 2024 Goal Date For Humira Biosimilar
Sep 20 2023
•
By
Dave Wallace
Alvotech has been given a 24 February goal date for AVT02 • Source: Shutterstock
More from Biosimilars
More from Products